Catherine Szyman - Edwards Lifesciences Insider

EW -- USA Stock  

USD 153.60  0.49  0.32%

Corporate Vice President Critical Care

Ms. Catherine M. Szyman was Corporationrationrate Vice President, Critical Care of Edwards Lifesciences Corporationrationration since January 2015. Prior to 2015, she was employed for more than 20 years at Medtronic, Inc., where she served as its Senior Vice President and President of Medtronic global diabetes business from 2009 to 2014, overseeing research, development, operations, sales and marketing for Medtronic insulin infusion pumps and continuous glucose monitoring systems. Prior to that, she held a variety of leadership roles at Medtronic, including Senior Vice President of Global Channel Management and Corporationrationrate Strategy and Business Development, Vice President and General Manager of Endovascular Innovations and Vice President of Finance for the Vascular Business
Age: 49  President Since 2015  MBA    
949-250-2500  http://www.edwards.com
Szyman previously served on the boards of Tornier, Inspire Medical Systems, and the California Healthcare Institute. She graduated from the University of St. Thomas, and earned her MBA from Harvard Business School.

Catherine Szyman Latest Insider Activity

Management Efficiency

The company has Return on Asset (ROA) of 11.51 % which means that for every $100 of asset it generated profit of $11.51. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 18.7 % which means that it produced $18.7 on every 100 dollars invested by current stockholders.
The company reports 1.05 B of total liabilities with total debt to equity ratio (D/E) of 32.4 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 2.03 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Showing few of many executives

PRESIDENT Since

Timothy MantelGNC Holdings
2016
Cristiano FranziBaxter International
2017
David NeuAmerisourceBergen Corporation
2015
Peter FasoloJohnson Johnson
2016
Britt VitaloneMcKesson Corporation
2018
David NortonExpress Scripts Holding Company
2015
Jeffrey ShermanBecton Dickinson and Company
2006
Erin LampertMcKesson Corporation
N/A
Lisa CapodiciCardinal Health
2017
Brik EyreBaxter International
2017
Joseph WolkJohnson Johnson
2016
Peyton HowellAmerisourceBergen Corporation
2017
Meghan FitzGeraldCardinal Health
2015
Robert FelicelliBaxter International
2015
Nabil ShabshabBecton Dickinson and Company
2011
KarpBaxter International
2016
William TozziBecton Dickinson and Company
2018
Christine HoustonExpress Scripts Holding Company
2018
Andrew FryeBaxter International
2017
Dale DanilewitzAmerisourceBergen Corporation
2014
Sun ParkAmerisourceBergen Corporation
2016

Entity Summary

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in USA and traded on New York Stock Exchange. It employs 12200 people.Edwards Lifesciences Corporation (EW) is traded on New York Stock Exchange in USA. It is located in CALIFORNIA, U.S.A and employs 12,200 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.

Edwards Lifesciences Leadership Team

John Cardis, Director
Wesley Schack, Director, MBA
Larry Wood, VP, MBA
Nicholas Valeriani, Director, MBA
Leslie Heisz, Director, MBA
Catherine Szyman, President, MBA
Martha Marsh, Director, MBA
Huimin Wang, President, MBA
Barbara McNeil, Director, Ph.D
Steven Loranger, Director
William Link, Director
Scott Ullem, CFO, MBA
Patrick Verguet, VP, Ph.D
Kieran Gallahue, Director, MBA
Bernard Zovighian, President, MBA
David Erickson, President
Donald Bobo, VP
Michael Mussallem, Chairman, Ph.D

Stock Performance Indicators

Did you try this?

Run Portfolio Rebalancing Now
   

Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Portfolio Rebalancing

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Edwards Lifesciences and Express Scripts Holding. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.